Evidence map›Paper›PMID 34392403›Full record

Trial reportClinical oral investigations2022

The effect of Brazilian propolis type-3 against oral microbiota and volatile sulfur compounds in subjects with morning breath malodor.

Marcelo de Faveri, Giselle Cancine Pupio, Hyun Koo, Bruno Bueno-Silva, Kelson Marinho de Oliveira, Luciene Cristina Figueiredo, Pedro Luiz Rosalen, Roberto Masayuki Hayacibara, Mitsue Fujimaki

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Clinical oral investigations, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Marcelo de FaveriDental Research Division, Department of Periodontology, Guarulhos University, São Paulo, Brazil. mdfaveri@uol.com.br.
Giselle Cancine PupioState University of Maringá, Maringá, Paraná, Brazil.
Hyun KooDepartment of Orthodontics, Division of Community Oral Health, Division of Pediatric Dentistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, USA.
Bruno Bueno-SilvaDental Research Division, Department of Periodontology, Guarulhos University, São Paulo, Brazil.ORCID http://orcid.org/0000-0003-3275-5910
Kelson Marinho de OliveiraDental Research Division, Department of Periodontology, Guarulhos University, São Paulo, Brazil.
Luciene Cristina FigueiredoDental Research Division, Department of Periodontology, Guarulhos University, São Paulo, Brazil.
Pedro Luiz RosalenFaculty of Dentistry of Piracicaba, State University of Campinas, São Paulo, Brazil.
Roberto Masayuki HayacibaraState University of Maringá, Maringá, Paraná, Brazil.
Mitsue FujimakiState University of Maringá, Maringá, Paraná, Brazil.
Guarulhos University · BRUniversidade Estadual de Maringá · BRUniversidade Estadual de Campinas (UNICAMP) · BRUniversity of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo evaluate propolis type-3 mouthrinse effects on the concentration of volatile sulfur compounds (VSCs) and on tongue dorsum microbial profile. MATERIALS AND

methodsA three-step double-blind, crossover, randomized study with 10 individuals divided into three groups: I-placebo (P); II-ethanolic extract of propolis type-3 3% (EEP); and III-chlorhexidine 0.12% (CHX) and instructed to rinse twice daily for 5 days. Each experimental period was followed by a 21-day washout interval. Morning mouth breath was assessed by VSC concentrations and microbiological samples were obtained from tongue dorsum at baseline and the end of period of rinses and analyzed using checkerboard DNA-DNA hybridization technique for 39 bacterial species.

resultsCHX and EEP presented the lowest VSC concentration when compared with placebo (p < 0.05). Even in the absence of mechanical plaque control, CHX and EEP treatments reduced VSC levels and there were no statistical differences for VSC measurement between CHX and EEP. There was a significant reduction in mean counts of 10 species including some VSC producers (Prevotella intermedia, Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia) by EEP. Total counts of organisms, gram-negative and gram-positive bacterial species showed a decrease for EEP and CHX (p < 0.05). In addition, no statistical difference was observed between EEP and CHX (p > 0.05). A positive correlation was observed between decrease of bacterial counts and decrease of VCSs concentration for the EEP and CHX.

conclusionsThe use of a 3% propolis type-3 mouthrinse is an effective way to prevent morning bad breath. Thus, propolis may be a promising agent for the treatment of halitosis. CLINICAL RELEVANCE: Propolis type-3 may be used as adjuvant treatment for morning breath malodor.

Indexed as

HalitosisMicrobiotaPropolisHumansMouthwashesSulfur CompoundsTongueMouthwashesPropolisSulfur CompoundsBiofilmClinical trialHalitosisPropolis

Identifiers

PMID34392403
OpenAlexW3194057307

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.